A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)

NCT01275066 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

177

Enrollment

INDUSTRY

Sponsor class

Conditions

MPS IV A

Interventions

DRUG: BMN 110 Weekly
DRUG: Placebo
DRUG: BMN 110 Every Other Week

Sponsor

BioMarin Pharmaceutical